Wang’s group also demonstrated that treating multiple myeloma cell lines highly expressing FASN with cerulenin, an inhibitor of FASN, inhibited its activity and induced apoptosis, suggesting that FASN can be a potential target in the treatment of multiple myeloma [34]. Here, FASN is linked to AL amyloidosis.